2023
DOI: 10.1016/j.xkme.2022.100577
|View full text |Cite
|
Sign up to set email alerts
|

Health Disparities in Kidney Failure Among Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-Sectional Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 42 publications
0
4
0
Order By: Relevance
“…The study population from which this cohort was identified has been previously described [ 4 , 14 , 27 ]. In brief, the study population included patients of any age with a minimum of 1-year continuous membership in the health plan.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…The study population from which this cohort was identified has been previously described [ 4 , 14 , 27 ]. In brief, the study population included patients of any age with a minimum of 1-year continuous membership in the health plan.…”
Section: Methodsmentioning
confidence: 99%
“…There is interfamilial and intrafamilial variability in the natural course of ADPKD [ 9 13 ]. In addition, we previously described differences in prevalence of and also progression to ESKD among different race/ethnic patients with ADPKD by race and ethnicity [ 4 , 14 ]. While 50% of patients progress to ESKD by their sixth decade of life, the decline in eGFR typically occurs rapidly later in adulthood due to initial compensatory glomerular hyperfiltration.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…8, 19 We previously characterized and described an ADPKD cohort and observed racial/ethnic differences in the proportion of patients with kidney failure, age of kidney failure onset, and likelihood of having had kidney transplantation. 20 Thus, approaches to identify rapid progressors early in the disease course with readily available clinical data and considering population diversity are warranted.…”
Section: Introductionmentioning
confidence: 99%